Expand All | Collapse All
Jeffrey S. Berns, MD, Chair
Dr. Berns is Professor of Medicine and Pediatrics at the Perelman School of Medicine at the University of Pennsylvania, where he is Associate Dean for Graduate Medical Education, Associate Chief of the Renal, Electrolyte, and Hypertension Division, and Director of the Nephrology Fellowship Training Program. Dr. Berns maintains a general nephrology practice at the Hospital of the University of Pennsylvania. He is a board certified internist and nephrologist.
Dr. Berns was in private practice, first in Northern Virginia, then in Philadelphia, for about 12 years before joining the faculty of the University of Pennsylvania in 1999.
Dr. Berns serves as Dialysis Section co-Editor for UpToDate and is Co-Deputy Editor of American Journal of Kidney Disease. He is Chair of the American Board of Internal Medicine (ABIM)'s Nephrology Board and Chair-Elect of the ABIM Council. He also served previously on the ABIM Nephrology Board Exam Committee and the ABIM Nephrology Self-Assessment Committee. He is Immediate Past President of the National Kidney Foundation. He has received numerous teaching awards, including the Christian R. and Mary F. Lindback Award for Distinguished Teaching from the University of Pennsylvania. He is also the recipient of the Exemplar of Humanism in Medicine Award from the College of Physicians of Philadelphia. He has been regularly honored in Philadelphia Magazine as a “Philadelphia Top Doc” and as one of America's “Top Docs” in nephrology.
Dr. Berns received his medical degree from Case Western Reserve University in Cleveland, Ohio. He completed his internal medicine internship at University Hospitals of Cleveland and then his nephrology fellowship at Yale University.
As of March 2019, Dr. Berns reported the following external relationships:
Work as an author or editor for following companies, with compensation as listed:
- American Journal of Kidney Diseases, receiving compensation as Deputy Editor.
- UpToDate, receiving compensation for authorship and editorial services.
Deborah B. Adey, MD
Dr. Adey MD is a transplant Nephrologist at the University of California, San Francisco (UCSF) and the medical director of the kidney transplant program at UCSF. She had the honor of participating in all aspects of transplant Nephrology from donor evaluations, pre-transplant evaluations, in-hospital care, and post-transplant follow-up.
She came to UCSF after completing her Nephrology fellowships at the University of Vermont followed by another two years of Nephrology at Mayo Clinic Rochester where she completed her research in protein metabolism in chronic kidney disease, and focused clinically on kidney transplantation. She did a post-doctoral year of transplant, as this was before the days of transplant Nephrology Fellowships. During her career she has focused on education.
She has been the site fellowship director for general Nephrology at UCSF for a few years, then started the transplant Nephrology fellowship program at UCSF which she has ran for seven years. On a national level, she has been the chair of the Transplant Nephrology Accreditation Program for the American Society of Transplantation (AST) and subsequently the Chair of the board of managers for the Transplant Nephrology Fellowship Accreditation Program, an LLC subsidiary of the AST. She serves as a member of the American Board of Internal Medicine Nephrology Board.
Dr. Adey initially became board certified in Internal Medicine and Nephrology in 1996, and was recertified in 2006 and again in 2016 in both Internal Medicine and Nephrology.
As of June 2019, Dr. Adey reported the following external relationships:
Service on a research-related expert panel or advisory board for the following companies, with honoraria:
Dr. Adey serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- American Society of Transplantation, Board Member, receiving reimbursement for travel expenses.
Linda Awdishu, PharmD
Dr. Awdishu is Professor and Chair of Clinical Pharmacy and Director of Interprofessional Education and Simulation at the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences. She completed her Bachelor of Science in Pharmacy from the University of Toronto in 1999, and completed a Masters of Advanced Studies in Clinical Research from the University of California, San Diego in 2007. She completed her Doctor of Pharmacy from the University of Colorado in 2008.
She developed and currently practices in the Joint Commission certified UC San Diego Chronic Kidney Disease Program, a multidisciplinary clinic involving a nephrologist, pharmacist, social worker, dietitian and nurse providing care for patients with CKD stage 2-5. She serves as a member of the Internal Medicine Nephrology Board; she teaches in the third year pharmacy curriculum chairing the Therapeutics course and overseeing simulations for second and third year pharmacy students.
Dr. Awdishu is the recipient of numerous teaching awards from pharmacy students and residents as well as the UCSD Academic Senate Distinguished Teaching Award. Her research program involves pharmacokinetics and pharmacogenomics of drugs in kidney disease. She co-directed The International Drug Induced Renal Injury Consortium (DIRECT) in collaboration with The International Serious Adverse Event Consortium. The DIRECT study is investigating the genetic basis of serious drug induced renal injury, through a collaborative network comprised of leading clinical research centers from around the world. She is a co-investigator in the UAB-UCSD O'Brien Center for Acute Kidney Injury Research studying new novel biomarkers of acute kidney injury.
As of May 2019, Dr. Awdishu reported the following external relationships:
Dr. Awdishu serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- American Society of Nephrology, Programming Committee Member, receiving reimbursement for travel expenses.
Funding for salary support, paid to the University of California, San Diego, from the following not-for-profit healthcare-related organizations:
- National Institutes of Health, for a University of Alabama, Birmingham-University of California, San Diego O'Brien Center Grant.
Paul T. Conway
Mr. Conway is President of the American Association of Kidney Patients, America's oldest and largest independent kidney patient advocacy organization. He has managed kidney disease for thirty-seven years, including nearly three years on dialysis and, for the past twenty years, as a kidney transplant recipient. He was recently selected the National Institutes of Health (NIH) to serve as a Member of the External Evaluation Panel for the NIH Kidney Precision Medicine Project. In 2017, he was named by the US Food and Drug Administration as the Chair of the new FDA Patient Engagement and Advocacy Committee for medical devices. Mr. Conway is the recipient of a 2017 President's Medal from the American Society of Nephrology and serves as an inaugural Patient Voice Editor for the Clinical Journal of the American Society of Nephrology.
As a policy professional, he has served under four US presidents, three governors and in support of five presidential transitions. He served on the 2016-2017 Presidential Transition Team as the Team Lead for the U.S. Office of Personnel Management and has subsequently served as an appointed member on the 2017 and 2018 Presidential Rank Review Board, the body charged with evaluating and recommending top career government executives for performance recognition by the White House. Mr. Conway’s previous Federal posts have included Chief of Staff of the US Department of Labor for Secretary, Chief of Staff of the U.S. Office of Personnel Management, an agency Chief of Staff at the US Department of Homeland Security (DHS) and Special Assistant in the White House Office of National Drug Control Policy. For the Commonwealth of Virginia, he has served as the Deputy Secretary of Health and Human Resources, a member of the Board of Health Professions and on a special review team for state mental health system modernization.
Mr. Conway works extensively with Congressional leaders and officials across the Federal government and serves on multiple national boards including: The Kidney Health Initiative; the United Network for Organ Sharing Kidney Committee; the Center for Dialysis Innovation at the University of Washington; and is a member of the Federal legal and regulatory issue team for the Clinical Trials Transformation Initiative at Duke University. Currently, he is a member of the American Board of Internal Medicine Nephrology Board.
As of May 2018, Dr. Conway reported the following external relationships:
Work as an author or editor for following companies, with compensation as listed:
- Clinical Journal of the American Society of Nephrology, receiving compensation for role as Patient Voice Editor.
Mr. Conway serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- American Association of Kidney Patients, President and Member of Executive Committee, receiving reimbursement for travel expenses.
- Patient Access to Pain Relief Coalition, Chair of the Steering Committee, without compensation.
- Kidney Health Initiative, Member of Board of Directors, receiving reimbursement for travel expenses.
- Clinical Trial Transformation Initiative, Member of Regulatory Review Project Team, receiving honoraria.
- University of Washington, Center for Dialysis Innovation, Member of Patient Advisory Board, without compensation.
- Food and Drug Administration, Chair of Patient Engagement Advisory Committee.
- United Network for Organ Sharing, Member of Kidney Committee.
- National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, External Expert Evaluator for Kidney Precision Medicine Project.
Mr. Conway also reported serving on panels and as a faculty member for American Society for Nephrology Kidney Week.
Deidra C. Crews, MD
Dr. Crews is a board certified nephrologist and Associate Professor of Medicine in the Division of Nephrology and Associate Vice Chair for Diversity and Inclusion of the Department of Medicine at Johns Hopkins University School of Medicine. She is jointly appointed in the Johns Hopkins School of Nursing and holds faculty appointments with the Welch Center for Prevention, Epidemiology and Clinical Research, the Hopkins Center to Eliminate Cardiovascular Health Disparities and the Hopkins Center on Aging and Health.
Dr. Crews serves on the American Society of Nephrology (ASN) Diversity and Inclusion Committee (Chair, effective 2018), the Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team, the Advisory Panel on Addressing Disparities of the Patient-Centered Outcomes Research Institute, and on the editorial boards of Clinical Journal of the American Society of Nephrology and Advances in Chronic Kidney Disease. She represents ASN on the American College of Physicians' Council of Subspecialty Societies and has previously served as Chair of the ASN Chronic Kidney Disease Advisory Group. Additionally, Dr. Crews is a member of the American Board of Internal Medicine Nephrology Board.
She has received several awards for her research work, including the President's Research Recognition Award of the Johns Hopkins Urban Health Institute and the Ernest Everett Just Award in Medical and Public Health Research on African American Health and Quality of Life from the College of Charleston and the Medical University of South Carolina. She is a member of the National Academy of Medicine’s (NAM) Emerging Leaders Forum and was the inaugural Gilbert S. Omenn Anniversary Fellow of the NAM. She is a member of Alpha Omega Alpha Honor Medical Society.
Dr. Crews received her undergraduate degree from the University of Virginia and her medical degree from Saint Louis University. A graduate of the Osler Medical Training Program, she completed nephrology fellowship and a master's degree in clinical epidemiology at Johns Hopkins University.
As of March 2019, Dr. Crews reported the following external relationships:
Dr. Crews serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- American Society of Nephrology, Chair of Diversity and Inclusion Committee and Member of the Executive Committee, without compensation.
- National Kidney Foundation of Delaware/Maryland, Board of Directors Member, without compensation.
- American College of Physicians, Council of Subspecialist Societies, without compensation.
Samir K. Nangia, MD
Dr. Nangia, who is board certified in both Internal Medicine and Nephrology, is Chief of Staff at Methodist Mansfield Hospital and member of the Corporate Medical Board and ACO Board of Directors at Methodist Health System in Dallas,Texas. He is a practicing nephrologist with Dallas Renal Group and serves on the Board of Directors. He is also a Physician Development Coach at TCU/UNTHSC Medical School where he also serves on the Curriculum Oversight Team.
Dr. Nangia has served on numerous hospital committees including Chair of Quality Council, Pharmacy, and Ethics. He has been a clinical preceptor for the University of Texas Arlington Nurse Practitioner Program, a Problem-Based Learning Instructor for medical students at University of California, San Diego (UCSD), and taught the Clinical Examination and Reasoning Course at Medical College of Wisconsin. He has completed a basic science research fellowship at UCSD and Scripps Research Institute with publications in both Transplantation and American Journal of Kidney Disease.
Dr. Nangia is a member of the American Board of Internal Medicine Nephrology Board. He has served on the Practicing Nephrology Advisory Group (PNAG) within the American Society of Nephrology (ASN). As a member of PNAG, he has been awarded Faculty of ASN and been involved in several ASN educational activities including writing questions for the Kidney Self-Assessment Program. Dr. Nangia also serves on the RPA Education Committee and is the Co-Creator and Co-Course Director of National Nephrology Business Leadership program for Nephrology Fellows. He is also the co-Creator and co-Host of an FM radio show and podcast, “Doc Talk Live,” aimed at creating health awareness in the Dallas – Fort Worth area. Also, he is a joint venture partner with US Renal Care and FMC Dialysis Clinics and Medical Director of Acute Inpatient Dialysis for several hospitals.
Dr. Nangia received his undergraduate degree in chemical engineering from the University of Minnesota followed by employment at ExxonMobil prior to entering medical school. He completed his internal medicine training at the Medical College of Wisconsin followed by a research fellowship at the University of California, San Diego in nephrology. He is a Certified Physician Executive and recently completed a Coaching Fellowship in pursuit of being a certified physician development coach.
As of February 2019, Dr. Nangia reported the following external relationships:
Dr. Nangia serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- American Society of Nephrology, serving as a Practicing Nephrology Advisory Group Member, receiving travel reimbursement.
- Joint Venture Partner FMC & USRC in 10 Dialysis Units in Dallas Area.
- Inpatient Dialysis DFW Mid-Cities for FMC (five hospitals) serving as a Medical Director, compensation goes to nephrology practice.
- Co-creator and co-host of Medical Radio Show Doc Talk Live (doctalklive.com) on 104.9 FM/Yupp TV with more than 200 physician guests, funded by Health Care Organization and receiving no compensation.
- Inpatient Dialysis DFW Mid-Cities for FMC (5 hospitals) serving as a Medical Director, compensation goes to Nephrology practice.
- Co-Creator & co-Host of Medical Radio Show Doc Talk Live (doctalklive.com) on 104.9 FM/Yupp TV with over 200 physician guests. Funded by Health Care Organization and receiving no compensation.
- Co-Creator & co-Course Director of Nephrology Business Leadership University (NBLU) - Course that is designed for Nephrology Fellows from various programs across the US. Funded by US Renal Care and receiving no compensation.
- Assistant Clinical Professor of Medicine at University of California San Diego serving as a Voluntary faculty for nephrology fellows.
- ACO Methodist Board of Directors, serving as part of the physician oversight team for ACO; voluntary position.
Rudolph A. Rodriguez, MD
Dr. Rodriguez, a board certified internist and nephrologist, is the Director of the Hospital & Specialty Medicine Service Line at the VA Puget Sound Health Care System and a Professor and Vice Chair of the Department of Medicine at the University of Washington. His academic career has centered on his role as a Nephrology Fellowship Director, first at the University of California, San Francisco (1998-2007), and at the University of Washington (2007-2014).
Dr. Rodriguez serves as a member of the American Board of Internal Medicine Nephrology Board. He is also Chair of the Veteran Affairs Nephrology Field Advisory Committee.
Dr. Rodriguez attended Stanford University and earned his medical degree at the Charles Drew/UCLA Medical Education Program at the University of California, Los Angeles. He did his internal medicine residency at California Pacific Medical Center, and his nephrology fellowship training at the University of California, San Francisco.
As of September 2019, Dr. Rodriguez reported the following external relationships:
Work as an author or editor for following company, with compensation as listed:
- McGraw Hill, receiving compensation for authorship.
Dr. Rodriguez serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- Veterans Affairs, serving as Chair, of the Field Advisory Committee, without compensation
Gary G. Singer, MD
Dr. Singer is the founding partner of Midwest Nephrology Associates and a Medical Director of outpatient and inpatient dialysis facilities with Fresenius Kidney Care. He is also an Assistant Professor of Clinical Medicine at Washington University School of Medicine. He is certified in both Internal Medicine and Nephrology.
Previously, Dr. Singer was Associate Director of Transplant Nephrology at Barnes-Jewish Hospital and Washington University School of Medicine. He was an associate with Renal Consultants prior to starting his own practice.
Dr. Singer is a member of the American Board of Internal Medicine Nephrology Board. He is also on the Board of Directors of the Renal Physicians Association and serves as Vice Chair of their Education Committee and member of their Clinical Practice Committee. Dr. Singer served as Chair of the South Division Medical Advisory Board of Fresenius Medical Services as well as Chair of the Medical Advisory Board of the Nation Kidney Foundation of Eastern Missouri and Metro East. He was also involved in the design and implementation of a dialysis electronic health record with Fresenius Kidney Care. He also served as Chief of Medicine at Barnes-Jewish St. Peters Hospital.
Dr. Singer received his medical degree from the University of Toronto. He did his internal medicine training at St. Michael's Hospital and the Toronto General Hospital. He completed a combined research and clinical fellowship in nephrology and immunology at Brigham and Women's Hospital and Harvard Medical School.
As of September 2019, Dr. Singer reported the following external relationships:
Dr. Singer serves in significant roles with the following organization, receiving reimbursement or compensation as listed:
- Renal Physicians Association serving in multiple roles, including Member of Board of Directors, member of Clinical Practice Committee, Vice Chair of Education/Annual Meeting Planning Committee, without compensation.